![](/media/vdqhqzem/salmon.png)
Uppsala Reports editor
@UMCGlobalSafety
Herbals have been our go-to remedy for thousands of years, so why is it that we still know so little about their side-effects compared to modern medicines?
In this long reads episode, author Daniele Sartori elaborates further on the themes of his Uppsala Reports article on the issue of lack of research on herbal medicines. In his discussion with Drug Safety Matters podcast host Federica Santoro, Daniele covers potential solutions to this problem, such as how to encourage safety data collection for herbals, and how to improve nomenclature and regulation of herbals.
This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. Subscribe by visiting the Drug Safety Matters website.
Adverse effects to medicines are not just physical in nature, but can manifest as behavioural side-effects too. How do we diagnose and treat these complex ADRs?
Research / 02 May 2024
When it comes to pharmacovigilance in older patients, age alone is insufficient as a measure of adverse reaction risk. Here is what we should consider instead.
Research / 13 May 2024
The traditional “drug-event combination” approach is too simplistic for complex side effects such as behavioural changes. We must adjust our methodology to address this intricacy.
Research / 29 May 2024